SCHEDULE: Aspira Women's Health Files Schedule 13D Amendment

Aspira Women's Health Inc. has filed an amendment to its Schedule 13D, detailing a recent purchase of common stock and warrants by Jack W. Schuler and the Jack W. Schuler Living Trust.

Summary

• This filing is an amendment to a Schedule 13D, indicating a change in beneficial ownership of Aspira Women's Health Inc. (the Company) securities.
• The amendment specifically details a purchase transaction that occurred on June 5, 2026, involving the Jack W. Schuler Living Trust (the Trust).
• The Trust purchased 222,222 shares of the Company's Common Stock and a warrant to purchase an additional 300,000 shares of Common Stock.
• The June 2026 Warrant is exercisable at $0.75 per share for a period of three years from its issuance date.
• As of May 12, 2026, the Company reported 43,500,411 shares outstanding. With the shares purchased in the June 2026 Purchase Agreement, the total outstanding shares considered for ownership percentage is 46,800,411.
• Jack W. Schuler is identified as the sole trustee of the Jack W. Schuler Living Trust.
• Following this transaction, Jack W. Schuler beneficially owns 6,536 shares directly and shares control over 4,046,051 shares held by the Trust, totaling 4,052,587 shares, representing 8.7% of the class.
• The Jack W. Schuler Living Trust beneficially owns 4,046,051 shares, representing 8.6% of the class.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral; it represents a capital raise and a change in beneficial ownership, but lacks specific financial performance details or forward-looking guidance.

Positives

• The company has secured additional capital through a purchase agreement, indicating investor confidence or a strategic need for funding.
• The issuance of warrants provides potential for future capital infusion if exercised.
• The transaction was conducted under an exemption from registration requirements, suggesting a private placement to sophisticated investors.

Negatives

• The issuance of new shares and warrants dilutes the ownership percentage of existing shareholders.
• The purchase price for the shares and warrants is not explicitly stated in the Schedule 13D, but the warrant exercise price is $0.75.

Risks

• The dilutive effect of issuing new shares and warrants could negatively impact the earnings per share for existing shareholders.
• The company's reliance on private placements for capital may indicate challenges in accessing public markets or a need for immediate funding.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance from the company regarding its future outlook. However, the purchase of warrants suggests a potential for future capital raises if they are exercised.

Industry Context

StockSavvy.ai notes that private placements and warrant issuances are common capital-raising strategies for companies, particularly those in growth phases or seeking to strengthen their financial position. This type of transaction can be a signal of management's efforts to secure funding, but also introduces dilution for existing shareholders.

Related Party Transactions

• The purchase of securities by the Jack W. Schuler Living Trust, where Jack W. Schuler is the sole trustee, constitutes a transaction involving a significant beneficial owner and the issuer.

Stakeholder Impact

• Shareholders: Potential dilution of ownership percentage and earnings per share due to the issuance of new shares and warrants.
• Creditors: The capital infusion may strengthen the company's financial position, potentially benefiting creditors.
• Management: The transaction reflects ongoing efforts to manage the company's capital structure.

Next Steps

• The Jack W. Schuler Living Trust may exercise its warrant to purchase additional shares.
• The company may undertake further capital raises through similar private placements or other means.

Key Dates

Recommendation

The filing indicates a capital raise and a change in significant beneficial ownership, but lacks specific financial performance data or strategic updates that would warrant a stronger recommendation. Investors should monitor future filings for performance metrics and the potential exercise of warrants.

Keywords

Aspira Women's Health, Schedule 13D, Amendment, Jack W. Schuler, Jack W. Schuler Living Trust, Securities Purchase Agreement, Common Stock, Warrants, Beneficial Ownership, SEC Filing